Categorising visual hallucinations in early Parkinson’s disease
Objective: To categorise visual hallucinations (VHs) in a cohort of newly diagnosed Parkinson’s disease (PD) patients and determine associations with clinical characteristics. Background: Visual hallucinations…Disrupted Amplitude of Low-frequency Fluctuations and Causal Connectivity in Parkinson’s Disease with Apathy
Objective: We aimed to explore associated neural substrates changes in Parkinson’s disease (PD) with apathy via amplitude of low-frequency fluctuations (ALFF) and Granger Causality Analysis…Applying Intervention Mapping methodologies to enhance Data Completeness in Movement Disorders-related Scales
Objective: Describe the methodological steps and benchmarks needed to utilize Intervention Mapping as a strategy to enhance Data Completeness in Rating Scales relying on input…Validation of the Parkinson’s Disease Pain Symptoms Scale (PD-PSS): An interim report
Objective: To explore the psychometric properties of the PD-PSS. Background: Evaluating pain in PD patients can be a difficult issue in the everyday clinical practice.…Effects of droxidopa when measuring gait speed, kyphosis, and functional reach in Parkinson’s disease
Objective: To determine if droxidopa improves gait speed, kyphosis, and functional reach in Parkinson’s disease when added to routine care treatment. Background: Fall risk factors…Botulinum toxin in Essential Hand Tremor – A Randomized Double-Blind Placebo-Controlled study with Customized Injection Approach
Objective: To evaluate the safety and efficacy of incobotulinumtoxinA (IncoA) injection for treatment of Essential Tremor (ET). Background: In essential tremor and Parkinson's Disease tremor,…Improvement in Patient Perceived Quality of Life with DaxibotulinumtoxinA for Injection in Adults with Cervical Dystonia
Objective: We describe the quality of life outcome from an open-label trial of daxibotulinumtoxinA for injection (Daxi) in cervical dystonia (CD) as measured by the…Angiotensin-converting enzyme inhibitors are neuroprotective regarding APOE-mediated motor and non-motor experiences for Alzheimer’s dementia but not for dementia with Lewy bodies
Objective: To assess whether angiotensin-converting enzyme (ACE) inhibitors modulate associations of biofluid concentrations and activity of ACE with motor and non-motor experiences in dementia with…Abnormal signaling along the non-canonical molecular cascade GRK6/β-arrestin2/Akt/GSK-3β in the putamen is associated with tardive dyskinesia following chronic haloperidol exposure in a primate model
Objective: To investigate the neurochemical basis of tardive dyskinesia (TD) in an experimental primate model. Background: TD is a potentially irreversible motor complication occurring in…Demographic and Clinical Characteristics of Flunarizine Induced Parkinsonism: Nationwide Data Between 2000 and 2006 in Taiwan
Objective: The calcium channel blockers, such as flunarizine and cinnarizine, and rarely selective serotonin reuptake inhibitors and lithium can produce parkinsonism and tardive syndromes. Background:…
- « Previous Page
- 1
- …
- 11
- 12
- 13
- 14
- 15
- …
- 177
- Next Page »